Cargando…

A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is a serious and highly invasive epithelial malignancy that is closely associated with Epstein—Barr virus (EBV). Due to the lack of therapeutic vaccines for NPC, we selected EBV latent membrane protein 2 (LMP2) as a preferable targeting antigen to develop a lipid-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Mengran, Duan, Xing, Peng, Xingchen, Jin, Zhaohui, Huang, Hai, Xiao, Wen, Zheng, Qian, Deng, Yongqi, Fan, Na, Chen, Kepan, Song, Xiangrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tsinghua University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807982/ https://www.ncbi.nlm.nih.gov/pubmed/36618068 http://dx.doi.org/10.1007/s12274-022-5254-x

Ejemplares similares

Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
por: Duan, Xing, et al.
Publicado: (2023)

mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
por: Chen, Kepan, et al.
Publicado: (2022)

mRNA-based therapeutics: powerful and versatile tools to combat diseases
por: Qin, Shugang, et al.
Publicado: (2022)

LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustion
por: Xiang, Yu, et al.
Publicado: (2023)

Molecular Screening of Nasopharyngeal Carcinoma: Detection of LMP-1, LMP-2 Gene Expression in Vietnamese Nasopharyngeal Swab Samples
por: Lao, Thuan Duc, et al.
Publicado: (2019)

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
por: Qin, Shugang, et al.
Publicado: (2023)

Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022)

Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
por: Huang, Cheng, et al.
Publicado: (2022)

LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
por: Cai, Ting-Ting, et al.
Publicado: (2017)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)

Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs
por: Sohn, Dae-Hee, et al.
Publicado: (2015)

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma
por: Shair, Kathy H. Y., et al.
Publicado: (2018)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
por: Wakae, Kousho, et al.
Publicado: (2020)

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A
por: Du, Zi-Ming, et al.
Publicado: (2011)

Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
por: Chen, Yanping, et al.
Publicado: (2012)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
por: Yang, Lifang, et al.
Publicado: (2010)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma()
por: Ye, Qing, et al.
Publicado: (2019)

The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users()
por: Cui, Qian, et al.
Publicado: (2010)

Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma
por: Zheng, Shixing, et al.
Publicado: (2020)

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo
por: Tang, Xiaojun, et al.
Publicado: (2014)

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
por: Zhu, Shanli, et al.
Publicado: (2020)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
por: Trinh, Cua Thi Hong, et al.
Publicado: (2023)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma
por: Wang, Zifeng, et al.
Publicado: (2016)

EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma
por: Xu, San, et al.
Publicado: (2021)

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma
por: Yuan, Qi, et al.
Publicado: (2023)

mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)

Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes
por: Aga, M, et al.
Publicado: (2014)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8
por: Jiang, Yiqun, et al.
Publicado: (2015)

Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1
por: Morris, Mhairi A.
Publicado: (2019)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
por: Rutkowska, Justyna, et al.
Publicado: (2023)

Constructing Machine Tool Foundations Using an LMP Alloy
por: Zhang, Yi, et al.
Publicado: (2020)

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells
por: Liu, HaiDan, et al.
Publicado: (2009)

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
por: Cho, Seok-Goo, et al.
Publicado: (2015)

Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma
por: He, Jiang, et al.
Publicado: (2016)

LMP1‐positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling
por: Zhang, Zhibao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgvkjdg13bpmbdh5jpova7i12m